share_log

Beyond Lackluster Earnings: Potential Concerns For OK Science and Technology's (SZSE:001223) Shareholders

Beyond Lackluster Earnings: Potential Concerns For OK Science and Technology's (SZSE:001223) Shareholders

除了收益乏善可陳之外:OK Science and Technology(深圳證券交易所:001223)股東的潛在擔憂
Simply Wall St ·  04/18 18:41

OK Science and Technology Co., Ltd.'s (SZSE:001223) lackluster earnings announcement last week disappointed investors. We think there is more to the story than simply soft profit numbers. Our analysis shows that there are some other factors of concern.

OK 科學與技術有限公司's (SZSE: 001223) 上週公佈的業績乏善可陳令投資者失望。我們認爲,這個故事不僅僅是軟利潤數字。我們的分析表明,還有其他一些令人擔憂的因素。

earnings-and-revenue-history
SZSE:001223 Earnings and Revenue History April 18th 2024
SZSE: 001223 2024 年 4 月 18 日的收益和收入歷史記錄

Examining Cashflow Against OK Science and Technology's Earnings

將現金流與OK Science and Technology的收益對

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

在高金融領域,用於衡量公司將申報的利潤轉化爲自由現金流(FCF)的效果的關鍵比率是應計比率(來自現金流)。簡而言之,該比率從淨利潤中減去FCF,然後將該數字除以公司在此期間的平均運營資產。你可以將現金流的應計比率視爲 “非FCF利潤率”。

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.

這意味着負應計比率是一件好事,因爲它表明該公司帶來的自由現金流比其利潤所暗示的要多。這並不意味着我們應該擔心應計比率爲正,但值得注意的是,應計比率相當高的地方。值得注意的是,有一些學術證據表明,總的來說,高應計率對短期利潤來說是個壞兆頭。

For the year to December 2023, OK Science and Technology had an accrual ratio of 0.47. As a general rule, that bodes poorly for future profitability. And indeed, during the period the company didn't produce any free cash flow whatsoever. Even though it reported a profit of CN¥113.9m, a look at free cash flow indicates it actually burnt through CN¥317m in the last year. We also note that OK Science and Technology's free cash flow was actually negative last year as well, so we could understand if shareholders were bothered by its outflow of CN¥317m. Having said that, there is more to the story. The accrual ratio is reflecting the impact of unusual items on statutory profit, at least in part.

在截至2023年12月的一年中,OK Science and Technology的應計比率爲0.47。通常,這對未來的盈利能力來說是個壞兆頭。事實上,在此期間,該公司沒有產生任何自由現金流。儘管該公司公佈了1.139億加元的利潤,但從自由現金流來看,它實際上在去年消耗了3.17億加元。我們還注意到,OK Science and Technology去年的自由現金流實際上也爲負數,因此我們可以理解股東是否因其3.17億元的流出而感到困擾。話雖如此,故事還有更多。應計比率至少部分反映了不尋常項目對法定利潤的影響。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

On top of the noteworthy accrual ratio and the spike in non-operating revenue, we can also see that OK Science and Technology benefitted from unusual items worth CN¥88m in the last twelve months. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. OK Science and Technology had a rather significant contribution from unusual items relative to its profit to December 2023. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.

除了值得注意的應計比率和營業外收入的激增外,我們還可以看到,在過去的十二個月中,OK Science and Technology受益於價值8800萬元人民幣的不尋常項目。我們不能否認更高的利潤通常會讓我們感到樂觀,但如果利潤是可持續的,我們更願意這樣做。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。這正如你所預料的那樣,因爲這些增強被描述爲 “不尋常”。截至2023年12月,OK Science and Technology從不尋常的項目中獲得了相當大的利潤。在其他條件相同的情況下,這可能會使法定利潤成爲衡量潛在盈利能力的不良指導。

Our Take On OK Science and Technology's Profit Performance

我們對OK科學與技術盈利表現的看法

Summing up, OK Science and Technology received a nice boost to profit from unusual items, but could not match its paper profit with free cash flow. On reflection, the above-mentioned factors give us the strong impression that OK Science and Technology'sunderlying earnings power is not as good as it might seem, based on the statutory profit numbers. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. Every company has risks, and we've spotted 1 warning sign for OK Science and Technology you should know about.

總而言之,OK Science and Technology從不尋常的項目中獲得了不錯的利潤提振,但其紙面利潤無法與自由現金流相提並論。經過反思,上述因素給我們留下了強烈的印象,即根據法定利潤數字,OK Science and Technology的潛在盈利能力並不像看起來那樣好。因此,如果你想更深入地研究這隻股票,那麼考慮它面臨的任何風險至關重要。每家公司都有風險,我們發現了一個你應該知道的OK Science and Technology的警告信號。

Our examination of OK Science and Technology has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

我們對OK Science and Technology的審查側重於某些可能使其收益看起來好於實際的因素。而且,在此基礎上,我們有些懷疑。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論